Viridian Therapeutics, Inc./DE
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-2.23 | $-1.80 |
| FY2020 | $-3.46 | $-2.10 |
| FY2021 | $-2.22 | $-2.15 |
| FY2022 | $-4.05 | $-2.37 |
| FY2023 | $-5.31 | $-2.74 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-2.23 | $-1.80 |
| FY2020 | $-3.46 | $-2.10 |
| FY2021 | $-2.22 | $-2.15 |
| FY2022 | $-4.05 | $-2.37 |
| FY2023 | $-5.31 | $-2.74 |